Skip to main content
Canada’s most-awarded newsroom for a reason
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
Canada’s most-awarded newsroom for a reason
$1.99
per week
for 24 weeks
// //

U.S. soldiers inspect the site where an Iranian missile hit at Ain al-Asad air base in Anbar province, Iraq, January 13, 2020.

JOHN DAVISON/Reuters

The United States treated 11 of its troops for symptoms of concussion after an Iranian missile attack on an Iraqi base where U.S. forces were stationed, the U.S. military said on Thursday, after initially saying no service members were hurt.

The attack was retaliation for a U.S. drone strike in Baghdad on Jan. 3 that killed Qassem Soleimani, the commander of the elite Quds Force of Iran’s Revolutionary Guard.

President Donald Trump and the U.S. military had said there were no casualties after the strike on the Ain al-Asad air base in western Iraq and a facility in its northern Kurdish region.

Story continues below advertisement

“While no U.S. service members were killed in the Jan. 8 Iranian attack on Al Asad air base, several were treated for concussion symptoms from the blast and are still being assessed,” Captain Bill Urban, spokesman for U.S. Central Command, said in a statement.

As a measure of caution, some service members were taken to U.S. facilities in Germany or Kuwait for “follow-on screening,” he added.

“When deemed fit for duty, the service members are expected to return to Iraq.”

As many as 1,500 Americans were deployed at the vast base deep in Iraq’s Anbar desert.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies